NCT01412502

Brief Summary

This study concerns the nearest relatives of patients who have passed away within 3 days of admission to an ICU due to: (1) brain death with multiple organ donation +/- tissues or (2) death via limitation and / or cessation of active treatment (LATA) without brain death or (3) sudden death of a previously healthy patient (no physical or mental limitations; MacCabe score = 0) within 3 days of admission to ICU without LATA nor brain death. Our primary objective is to determine the proportion of nearest relatives at risk for post traumatic stress disorder as defined by an Impact of Event Scale score greater than 37, and to compare this factor between the three above-mentioned groups.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
119

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2012

Longer than P75 for all trials

Geographic Reach
1 country

6 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 8, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 9, 2011

Completed
10 months until next milestone

Study Start

First participant enrolled

June 15, 2012

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 28, 2016

Completed
Last Updated

January 3, 2018

Status Verified

January 1, 2018

Enrollment Period

4 years

First QC Date

August 8, 2011

Last Update Submit

January 2, 2018

Conditions

Keywords

Tissue DonorsTissue and Organ ProcurementBrain deathWithdrawal of life support

Outcome Measures

Primary Outcomes (1)

  • IES-R > 37: yes/no

    Impact of Event Scale score greater than 37: yes/no

    6 weeks

Secondary Outcomes (2)

  • IES-R

    6 weeks

  • HDAS score

    6 weeks

Study Arms (3)

Brain death with organ donation

Participants in this group are the nearest relatives (or "person-of-trust") of a patient who has passed away within 3 days of admission to an intensive care unit. The cause of death includes brain death with multiple organ donation +/- tissues.

Other: IES-R and HDAS scores

Limitation/cessation of active treatment

Participants in this group are the nearest relatives (or "person-of-trust") of a patient who has passed away within 3 days of admission to an intensive care unit. The cause of death includes limitation/cessation of active treatment without brain death.

Other: IES-R and HDAS scores

Sudden death

Participants in this group are the nearest relatives (or "person-of-trust") of a patient who has passed away within 3 days of admission to an intensive care unit. The cause of death was sudden death of a previously healthy patient (no physical or mental limitations; MacCabe score = 0) within 3 days of admission to ICU without LATA nor brain death.

Other: IES-R and HDAS scores

Interventions

The Impact of Event Scale and Hospital Depression and Anxiety Score questionnaires are administered to participants.

Brain death with organ donationLimitation/cessation of active treatmentSudden death

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants are the nearest relatives (or "person-of-trust") of a patient who has passed away in an intensive care unit (ICU) due to: (1) brain death with multiple organ donation +/- tissues or (2) death via limitation and / or cessation of active treatment (LATA) without brain death or (3) sudden death of a previously healthy patient (no physical or mental limitations; MacCabe score = 0) within 3 days of admission to ICU without LATA nor brain death

You may qualify if:

  • Participants are the nearest relatives (or "person-of-trust") of a patient who has passed away in an intensive care unit (ICU). The cause of death must fall into 1 of the following three categories: (1) brain death with multiple organ donation +/- tissues; (2) death via limitation and / or cessation of active treatment (LATA) without brain death; (3) sudden death of a previously healthy patient (no physical or mental limitations; MacCabe score = 0) within 3 days of admission to ICU without LATA nor brain death
  • The participant must be one of the following (roman numerals indicate prioritization in choice of participants, if needed): (i) designated "person-of-trust"; (ii) spouse/partner of the deceased; (iii) parent of the deceased; (iv) child of the deceased; (v) sibling of the deceased.

You may not qualify if:

  • Patient deceased after 3 days of ICU care without LATA
  • The deceased was under 18 years old
  • The deceased was over 70 years old
  • Refusal to participated
  • Participant does not speak French
  • The participant is under judicial protection, under tutorship or curatorship
  • The participant is deaf or mute
  • The deceased has no nearest relative

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Hôpital Beaujon -APHP

Clichy, France

Location

Assistance Publique - Hopitaux de Marseille

Marseille, France

Location

CHU Lapeyronie

Montpellier, 34295, France

Location

Hôpital Gui De Chauliac (CHU de Montpellier)

Montpellier, 34295, France

Location

Centre Hospitalier Universitaire de Nîmes

Nîmes, 30029, France

Location

Hôpital Kremlin Bicêtre - APHP

Paris, France

Location

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticBrain Death

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesComaUnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jean Yves Lefrant, MD PhD

    Centre Hospitalier Universitaire de Nîmes

    STUDY DIRECTOR
  • Caroline Boutin, MD

    Centre Hospitalier Universitaire de Nîmes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 8, 2011

First Posted

August 9, 2011

Study Start

June 15, 2012

Primary Completion

June 28, 2016

Study Completion

June 28, 2016

Last Updated

January 3, 2018

Record last verified: 2018-01

Locations